Annual Accounts Receivable
$25.15 M
+$2.96 M+13.35%
31 December 2023
Summary:
AxoGen annual accounts receivable is currently $25.15 million, with the most recent change of +$2.96 million (+13.35%) on 31 December 2023. During the last 3 years, it has risen by +$6.99 million (+38.49%). AXGN annual accounts receivable is now at all-time high.AXGN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$24.63 M
-$523.00 K-2.08%
30 September 2024
Summary:
AxoGen quarterly accounts receivable is currently $24.63 million, with the most recent change of -$523.00 thousand (-2.08%) on 30 September 2024. Over the past year, it has dropped by -$518.00 thousand (-2.06%). AXGN quarterly accounts receivable is now -2.08% below its all-time high of $25.15 million, reached on 30 June 2024.AXGN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AXGN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -2.1% |
| 3 y3 years | +38.5% | +35.6% |
| 5 y5 years | +48.4% | +45.4% |
AXGN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.5% | -2.1% | +35.6% |
| 5 y | 5 years | at high | +48.4% | -2.1% | +89.2% |
| alltime | all time | at high | >+9999.0% | -2.1% | >+9999.0% |
AxoGen Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $24.63 M(-2.1%) |
| June 2024 | - | $25.15 M(+3.9%) |
| Mar 2024 | - | $24.21 M(-3.7%) |
| Dec 2023 | $25.15 M(+13.3%) | $25.15 M(+8.1%) |
| Sept 2023 | - | $23.26 M(+7.8%) |
| June 2023 | - | $21.57 M(-3.2%) |
| Mar 2023 | - | $22.28 M(+0.4%) |
| Dec 2022 | $22.19 M(+22.2%) | $22.19 M(+3.9%) |
| Sept 2022 | - | $21.36 M(+4.9%) |
| June 2022 | - | $20.37 M(+9.6%) |
| Mar 2022 | - | $18.59 M(+2.4%) |
| Dec 2021 | $18.16 M(+3.1%) | $18.16 M(-2.2%) |
| Sept 2021 | - | $18.57 M(+2.1%) |
| June 2021 | - | $18.18 M(-8.3%) |
| Mar 2021 | - | $19.82 M(+12.5%) |
| Dec 2020 | $17.62 M(+4.0%) | $17.62 M(-6.1%) |
| Sept 2020 | - | $18.76 M(+33.5%) |
| June 2020 | - | $14.05 M(+7.9%) |
| Mar 2020 | - | $13.02 M(-23.2%) |
| Dec 2019 | $16.94 M(+10.6%) | $16.94 M(+9.7%) |
| Sept 2019 | - | $15.45 M(-5.1%) |
| June 2019 | - | $16.29 M(+7.2%) |
| Mar 2019 | - | $15.19 M(-0.8%) |
| Dec 2018 | $15.32 M(+38.5%) | $15.32 M(+9.5%) |
| Sept 2018 | - | $13.99 M(+13.2%) |
| June 2018 | - | $12.36 M(+5.0%) |
| Mar 2018 | - | $11.77 M(+6.3%) |
| Dec 2017 | $11.06 M(+37.4%) | $11.06 M(+8.5%) |
| Sept 2017 | - | $10.20 M(+8.3%) |
| June 2017 | - | $9.42 M(+12.4%) |
| Mar 2017 | - | $8.38 M(+4.1%) |
| Dec 2016 | $8.05 M(+68.4%) | $8.05 M(+15.0%) |
| Sept 2016 | - | $7.00 M(+15.4%) |
| June 2016 | - | $6.07 M(+14.8%) |
| Mar 2016 | - | $5.29 M(+10.6%) |
| Dec 2015 | $4.78 M | $4.78 M(+3.0%) |
| Sept 2015 | - | $4.64 M(+21.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $3.84 M(+21.4%) |
| Mar 2015 | - | $3.16 M(+10.1%) |
| Dec 2014 | $2.87 M(+51.7%) | $2.87 M(+4.7%) |
| Sept 2014 | - | $2.74 M(+8.5%) |
| June 2014 | - | $2.53 M(+28.6%) |
| Mar 2014 | - | $1.97 M(+3.8%) |
| Dec 2013 | $1.89 M(+80.3%) | $1.89 M(+8.8%) |
| Sept 2013 | - | $1.74 M(+22.9%) |
| June 2013 | - | $1.42 M(+20.0%) |
| Mar 2013 | - | $1.18 M(+12.3%) |
| Dec 2012 | $1.05 M(+31.6%) | $1.05 M(+13.5%) |
| Sept 2012 | - | $925.50 K(+7.3%) |
| June 2012 | - | $862.20 K(-3.6%) |
| Mar 2012 | - | $894.00 K(+12.1%) |
| Dec 2011 | $797.70 K(+95.9%) | $797.70 K(+48.2%) |
| Sept 2011 | - | $538.10 K(+32.1%) |
| Dec 2010 | $407.30 K(+305.7%) | $407.30 K(+2809.3%) |
| Sept 2008 | - | $14.00 K(+62.8%) |
| June 2008 | - | $8600.00(-64.0%) |
| Mar 2008 | - | $23.90 K(-76.2%) |
| Dec 2007 | $100.40 K(-53.3%) | $100.40 K(+12.3%) |
| Mar 2006 | - | $89.40 K(-58.4%) |
| Dec 2005 | $214.90 K(-32.6%) | $214.90 K(>+9900.0%) |
| June 2004 | - | $700.00(-99.3%) |
| Mar 2004 | - | $100.30 K(+37.2%) |
| Sept 2003 | - | $73.10 K(-59.7%) |
| June 2003 | - | $181.40 K(-3.0%) |
| Mar 2003 | - | $187.10 K(-41.3%) |
| Dec 2002 | $318.90 K(-34.6%) | $318.90 K(-52.9%) |
| June 2002 | - | $677.00 K(-27.5%) |
| Mar 2002 | - | $933.60 K(-21.2%) |
| Dec 2001 | $487.50 K(-67.9%) | - |
| Sept 2001 | - | $1.19 M(-22.0%) |
| June 2001 | $1.52 M(-36.7%) | $1.52 M(-36.3%) |
| Mar 2001 | - | $2.39 M(+8.9%) |
| Dec 2000 | - | $2.19 M(-8.7%) |
| June 1999 | $2.40 M | $2.40 M |
FAQ
- What is AxoGen annual accounts receivable?
- What is the all time high annual accounts receivable for AxoGen?
- What is AxoGen quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for AxoGen?
- What is AxoGen quarterly accounts receivable year-on-year change?
What is AxoGen annual accounts receivable?
The current annual accounts receivable of AXGN is $25.15 M
What is the all time high annual accounts receivable for AxoGen?
AxoGen all-time high annual accounts receivable is $25.15 M
What is AxoGen quarterly accounts receivable?
The current quarterly accounts receivable of AXGN is $24.63 M
What is the all time high quarterly accounts receivable for AxoGen?
AxoGen all-time high quarterly accounts receivable is $25.15 M
What is AxoGen quarterly accounts receivable year-on-year change?
Over the past year, AXGN quarterly accounts receivable has changed by -$518.00 K (-2.06%)